| Literature DB >> 17035144 |
Alfred Bernard1, Sylviane Carbonnelle, Claire de Burbure, Olivier Michel, Marc Nickmilder.
Abstract
The pool chlorine hypothesis postulates that the rise in childhood asthma in the developed world could result at least partly from the increasing exposure of children to toxic gases and aerosols contaminating the air of indoor chlorinated pools. To further assess this hypothesis, we explored the relationships between childhood asthma, atopy, and cumulated pool attendance (CPA). We studied 341 schoolchildren 10-13 years of age who attended at a variable rate the same public pool in Brussels (trichloramine in air, 0.3-0.5 mg/m3). Examination of the children included a questionnaire, an exercise-induced bronchoconstriction (EIB) test, and the measurement of exhaled nitric oxide (eNO) and total and aeroallergen-specific serum IgE. CPA by children (range, 0-1,818 hr) emerged among the most consistent predictors of asthma (doctor diagnosed or screened with the EIB test) and of elevated eNO, ranking immediately after atopy and family history of asthma or hay fever. Although the risk of elevated eNO increased with CPA [odds ratio (OR) = 1.30; 95% confidence interval (CI), 1.10-1.43] independently of total or specific serum IgE, the probability of developing asthma increased with CPA only in children with serum IgE > 100 kIU/L (OR for each 100-hr increase in CPA = 1.79; 95% CI, 1.07-2.72). All these effects were dose related and most strongly linked to pool attendance before 6-7 years of age. Use of indoor chlorinated pools especially by young children interacts with atopic status to promote the development of childhood asthma. These findings further support the hypothesis implicating pool chlorine in the rise of childhood asthma in industrialized countries.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17035144 PMCID: PMC1626429 DOI: 10.1289/ehp.8461
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Respiratory symptoms, asthma, eNO, and serum IgE in children [no. (%)].
| Indicators | Boys ( | Girls ( | |
|---|---|---|---|
| Respiratory symptoms | |||
| Wheezing | 20 (11.6) | 12 (7.1) | 0.157 |
| Chest tightness | 9 (5.2) | 10 (5.9) | 0.770 |
| Shortness of breath | 12 (7.0) | 12 (7.1) | 0.964 |
| Cough | 35 (20.3) | 27 (16.0) | 0.307 |
| Total serum IgE | |||
| kIU/L (range) | 63.3 (6.7–3,204) | 69.7 (4.0–3,545) | 0.523 |
| > 100 kIU/L | 57 (32.9) | 60 (35.5) | 0.679 |
| Aeroallergen-specific serum IgE | |||
| Panel of 12 aeroallergens | 61 (35.3) | 47 (27.8) | 0.148 |
| House-dust mite | 40 (23.1) | 24 (14.2) | 0.037 |
| Dog | 6 (3.4) | 6 (3.6) | 0.950 |
| Cat | 14 (8.1) | 5 (4.7) | 0.041 |
| Pollen | 21 (12.1) | 17 (10.1) | 0.567 |
| eNO | |||
| Geometric mean [range (ppb)] | 11.0 (2.8–91.6) | 10.2 (3.2–101) | 0.290 |
| > 30 ppb | 16 (9.2) | 13 (7.7) | 0.606 |
| > 30 ppb (without doctor-diagnosed asthma) | 8 (4.6) | 11 (6.5) | 0.447 |
| Asthma | |||
| Doctor diagnosed | 18 (10.4) | 10 (5.9) | 0.065 |
| Screened with the EIB test | 6 (3.4) | 6 (3.6) | 0.736 |
| Total asthma (diagnosed and/or positive EIB test) | 24 (14.0) | 16 (9.5) | 0.198 |
| Doctor-diagnosed asthma and/or eNO > 30 ppb | 26 (15.1) | 18 (10.7) | 0.219 |
| Total asthma and/or eNO > 30 ppb | 32 (21.9) | 24 (16.5) | 0.273 |
Predictors of asthma and elevated eNO in children.
| Indicator | Predictors | OR | |
|---|---|---|---|
| Doctor-diagnosed asthma | Mother and/or father with asthma | 4.01 (1.68–9.55) | 0.0017 |
| Aeroallergen-specific serum IgE | 3.53 (1.57–7.95) | 0.0024 | |
| Sex (boy) | 2.65 (1.11–6.32) | 0.0284 | |
| CPA (100 hr) | 1.14 (0.99–1.31) | 0.0691 | |
| Pets from birth | 2.33 (0.93–5.85) | 0.0725 | |
| No. of siblings | 1.32 (0.97–1.81) | 0.0815 | |
| Total asthma (doctor diagnosed and/or screened with EIB test) | Aeroallergen-specific serum IgE | 2.76 (1.28–5.96) | 0.0095 |
| Total serum IgE (100 kIU/L) | 1.09 (1.02–1.16) | 0.0131 | |
| Mother and/or father with asthma | 2.40 (1.08–5.31) | 0.0310 | |
| Housing density (persons/room) | 3.30 (1.11–9.87) | 0.0320 | |
| CPA (100 hr) | 1.15 (0.99–1.31) | 0.0512 | |
| Pets from birth | 2.18 (0.94–5.04) | 0.0680 | |
| Household chlorine bleach | 0.46 (0.19–1.15) | 0.0960 | |
| eNO > 30 ppb | Aeroallergen-specific serum IgE | 21.1 (5.37–82.7) | < 0.0001 |
| CPA (100 hr) | 1.30 (1.10–1.43) | 0.0027 | |
| Total serum IgE (100 kIU/L) | 1.10 (1.02–1.19) | 0.0155 | |
| BMI (kg/m2) | 0.77 (0.63–0.95) | 0.0156 | |
| Pets during the previous 2 years | 0.22 (0.06–0.80) | 0.0216 | |
| Day nursery attendance | 0.32 (0.11–0.91) | 0.0329 | |
| Mother and/or father with hay fever | 2.73 (1.02–7.30) | 0.0461 | |
| Housing density (persons/room) | 2.69 (0.97–7.51) | 0.0584 | |
| eNO > 30 ppb without doctor-diagnosed asthma | Aeroallergen-specific serum IgE | 11.5 (2.57–51.5) | 0.0014 |
| Total serum IgE (100 kIU/L) | 1.09 (1.01–1.17) | 0.0255 | |
| Pets during the previous 2 years | 0.10 (0.01–0.83) | 0.0335 | |
| Housing density (persons/room) | 4.55 (1.09–18.9) | 0.0372 | |
| CPA (100 hr) | 1.22 (1.00–1.50) | 0.0490 | |
| Mother and/or father with hay fever | 2.95 (0.97–9.00) | 0.0570 | |
| eNO > 30 ppb and/or doctor-diagnosed asthma | Aeroallergen-specific serum IgE | 5.49 (2.66–11.3) | < 0.0001 |
| CPA (100 hr) | 1.19 (1.02–1.37) | 0.0135 | |
| No. of siblings | 1.33 (1.03–1.71) | 0.0273 | |
| Mother and/or father with hay fever | 2.11 (1.03–4.32) | 0.0422 | |
| Mother and/or father with asthma | 2.06 (0.90–4.69) | 0.0863 | |
| eNO > 30 ppb and/or total asthma | Aeroallergen-specific serum IgE | 4.11 (2.06–8.20) | < 0.0001 |
| Mother and/or father with hay fever | 2.65 (1.37–5.11) | 0.0038 | |
| Total serum IgE (100 kIU/L) | 1.09 (1.02–1.16) | 0.0128 | |
| CPA (100 hr) | 1.17 (1.02–1.33) | 0.0215 | |
| Housing density (persons/room) | 3.09 (1.15–8.26) | 0.0247 | |
| No. of siblings | 1.24 (0.98–1.57) | 0.0757 |
CI, confidence interval.
ORs calculated by multiple logistic regression analysis of 17 independent variables (detailed in “Materials and Methods”). The table lists only those associations emerging with a p < 0.1.
Risk of asthma and/or elevated eNO with CPA [OR (95% confidence interval)] in nonatopic and atopic children on the basis of total and aeroallergen-specific serum IgE.
| Total serum IgE
| Total serum IgE
| Aeroallergen-specific serum IgE
| Total serum IgE > 100 kIU/L and/or aeroallergen-specific serum IgE
| |||||
|---|---|---|---|---|---|---|---|---|
| Indicator | < 56 kIU/L ( | > 56 kIU/L ( | < 100 kIU/L ( | > 100 kIU/L ( | No ( | Yes ( | No ( | Yes ( |
| Doctor-diagnosed asthma | 1.12 (0.89–1.42)
| 1.34 (1.03–1.75)
| 1.03 (0.81–1.31)
| 1.57 (1.07–2.30)
| 1.12 (0.91–1.39)
| 1.25 (0.99–1.57)
| 0.99 (0.78–1.37)
| 1.29 (1.05–1.59)
|
| Total asthma (doctor diagnosed and/or screened with EIB test) | 1.11 (0.85–1.45)
| 1.42 (1.06–1.91)
| 0.98 (0.76–1.27)
| 1.79 (1.066–2.72)
| 1.07 (0.86–1.33)
| 1.20 (0.97–1.47)
| 0.99 (0.73–1.37)
| 1.27 (1.04–1.56)
|
| eNO > 30 ppb | 1.40 (0.99–1.96)
| 1.33 (1.03–1.72)
| 1.65 (1.19–2.28)
| 1.19 (0.86–1.64)
| 1.87 (1.07–3.29)
| 1.23 (0.96–1.58)
| 1.91 (1.08–3.37)
| 1.20 (0.94–1.53)
|
| eNO > 30 ppb, no diagnosed asthma | 1.42 (0.83–2.43)
| 1.27 (0.96–1.67)
| 1.62 (1.08–2.44)
| 1.07 (0.73 –1.58)
| 1.71 (0.97–3.03)
| 1.06 (0.78–1.45)
| 1.78 (0.99–3.20)
| 1.07 (0.79–1.46)
|
| eNO > 30 ppb and/or doctor-diagnosed asthma | 1.25 (1.04–1.51)
| 1.38 (1.01–1.88)
| 1.20 (1.02–1.42)
| 1.66 (1.11–2.49)
| 1.18 (1.01–1.38)
| 1.16 (0.94–1.43)
| 1.27 (1.04–1.55)
| 1.16 (0.97–1.40)
|
| eNO > 30 ppb and/or total asthma | 1.13 (0.92–1.38)
| 1.49 (1.09–2.04)
| 1.12 (0.97–1.31)
| 1.71 (1.13–2.61)
| 1.18 (1.01–1.38)
| 1.16 (0.94–1.43)
| 1.14 (0.97–1.35)
| 1.21 (0.99–1.48)
|
Adjusted ORs calculated for each 100 hr CPA and adjusted for covariates listed in Table 2.
Figure 1Prevalence of children with doctor-diagnosed or total asthma (A), with elevated eNO (B), or with doctor-diagnosed or total asthma and/or elevated eNO (C) according to the CPA in children with low or high total serum IgE. Total asthma refers to asthma diagnosed by a doctor and/or screened with the EIB test. The cutoff value of 56 kIU/L for total serum IgE corresponds to the 50th percentile of concentrations observed in the studied population. Statistical significance assessed by a chi-square test for trend.
Figure 2Prevalence of children with high total serum IgE or with aeroallergen-specific serum IgE according to CPA [error bars indicate 95% confidence interval (CI)]. The cutoff value of 56 kIU/L for total serum IgE corresponds to the 50th percentile of concentrations observed in the studied population. Numbers above error bars are upper limits of 95% CIs.
Figure 3Risk of developing asthma (total asthma, i.e., diagnosed by a doctor or screened with the EIB test) or of having elevated eNO (> 30 ppb) according to total serum IgE level and CPA over increasingly shorter periods of time after birth. The ORs have been adjusted for covariates listed in Table 2. The cutoff value of 56 kIU/L for total serum IgE corresponds to the 50th percentile of concentrations observed in the studied population.